What is ATXS's current stock price?

As of now, ATXS is trading at $12.63, with a daily change of +0.96%.

What is ATXS next earnings date?

ATXS next earnings report is scheduled for Nov 14, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ATXS Stock Analysis & IQ Rating | Astria Therapeutics Inc.

ATXS

Astria Therapeutics Inc.

$12.63

+$0.12 | +0.96%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 12.72

MKT CAP

$ 713.05M

52W Low

$ 3.56

VOL

$ 621.49K

P/E Ratio

N/A

AVG VOL

$ 2.91M

RSI

82.73

TREND

Uptrend

ATXS Stock IQ

Login to see Astria Therapeutics Inc. (ATXS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ATXS Target Price

Login to display

Strengths

ATXS Rewards

Earnings are forecast to grow

ATXS Rewards

Upgraded on attractively valued

Chart

$7.69 (+64.24%)

$6.28 (+101.11%)

$5.79 (+118.13%)

$10.09 (+25.17%)

1year

6month

3month

1month

ATXS Risk Level

ATXS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

ATXS Analysts Opinion

ATXS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ATXS Analysts Opinion

ATXS Analysts opinion is negative and it remained unchanged from the past 3 months

ATXS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

ATXS Street Opinion

ATXS Street view is extremely bullish and have positive views on the near-term outlook

ATXS Performance Sentiment

Sentiments overview associated with ATXS events and the stock performance.

100%

0%

Positive

Negative

9 out of 9
events present

0 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$12.43

Resistance
Price

$11.61

Current Price Range

$12.43

Show methods +

ATXS Earnings

The TTM reflects 12-month period, providing review of ATXS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

-

Operating Exp

131

112

68

+38.80%

Operating Inc

-131

-112

-68

-

Net Interest Inc

15

17

10

+22.47%

Interest Inc

15

17

10

+22.47%

Other Inc Exp

-15

-

EPS Growth

-2.02

-1.68

-2.42

-

ATXS Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.1

Next Earnings Date: Nov 14, 2025

ATXS Latest Analysis +

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX. ATXS stock jumps 37% after agreeing to a $700 million cash-and-stock buyout by BioCryst boosting the latters HAE treatment pipeline.

Wed Oct 15, 2025

$11.92 | +2.67%

Activity

Momentum

Astria Therapeutics: Pipeline And Market Potential Post BioCryst Acquisition.

Wed Oct 15, 2025

$11.92 | +2.67%

Activity

BioCryst Says Astria Therapeutics $700 Million Deal Gives Perfect Second Product Candidate. ) on Tuesday agreed to acquire ATXS) for a mix of cash and stock.The deal represents an implied value of $13 per Astria share and approximately .BioCryst will acquire all outstanding shares of Astria for consideration per share consisting of $8.55 in cash and 0.59 shares of BioCryst stock.Astria is a biopharmaceutical company focused on developing therapies for .Also Read: The transaction is expected in t

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

Potential

BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal . (RTTNews) - BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday said it has agreed to acquire Astria Therapeutics Inc. (ATXS) for an enterprise value of about $700 million to be paid in cash and stock. Following the announcement Astria shares surged more than 35% in pre-market tr

Tue Oct 14, 2025

$11.61 | +37.07%

Momentum

BioCryst to buy Astria Therapeutics for $13 per share (update).

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

BioCryst to Acquire Astria Therapeutics Strengthening Presence in HAE Transforming Growth Profile. – Deal to add navenibart a late-stage and long-acting plasma kallikrein inhibitor in Phase 3 clinical development to BioCrysts HAE portfolio –

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

BioCryst To Acquire Astria Therapeutics In $700 Mln Cash-and-Stock Deal . (RTTNews) - BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday announced it has entered into a definitive agreement to acquire Astria Therapeutics Inc. (ATXS) a biopharmaceutical company for cash and stock valued at approximately $13.00 per Astria share representing an enterpr

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

FAQ About ATXS Stock Insights

What is ATXS current stock price?

What are ATXS stock strengths?

What risks are associated with ATXS stock?

When is ATXS next earnings report?

What is ATXS market cap and volume?

What is ATXS's current Stock IQ?

Should I buy ATXS stock right now?

Is ATXS a Strong Buy right now?

What does a 'Strong Buy' rating mean for ATXS?

What does a 'Strong Sell' rating mean for ATXS?

What factors influence ATXS's Stock IQ?

Explore our ATXS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ATXS Stock Strategies
Effective Risk Management

FIND US ON

Receive our ATXS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ATXS

Astria Therapeutics Inc.

Current Price

$12.63

+$0.12 | +0.96%

52W High

$ 12.72

MKT CAP

$ 713.05M

52W Low

$ 3.56

VOL

$ 621.49K

P/E Ratio

N/A

AVG VOL

$ 2.91M

RSI

82.73

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ATXS Rewards

Earnings are forecast to grow

ATXS Rewards

Upgraded on attractively valued

ATXS Stock IQ

Login to unlock Astria Therapeutics Inc. (ATXS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$7.69 (+64.24%)

$6.28 (+101.11%)

$5.79 (+118.13%)

$10.09 (+25.17%)

1year

6month

3month

1month

ATXS Analysts Opinion

ATXS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ATXS Analysts Opinion

ATXS Analysts opinion is negative and it remained unchanged from the past 3 months

ATXS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

ATXS Street Opinion

ATXS Street view is extremely bullish and have positive views on the near-term outlook

ATXS Risk Level

ATXS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

ATXS Performance Sentiment

Sentiments overview associated with ATXS events and the stock performance.

100%

0%

Positive

Negative

9 out of 9
events present

0 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$12.43

Resistance
Price

$11.61

Current Price Range

$12.43

Show methods +

ATXS Earnings

The TTM data reflects the most recent 12-month period, providing overview of ATXS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

-

Operating Exp

131

112

68

+38.80%

Operating Inc

-131

-112

-68

-

Net Interest Inc

15

17

10

+22.47%

Interest Inc

15

17

10

+22.47%

Other Inc Exp

-15

-

EPS Growth

-2.02

-1.68

-2.42

-

ATXS Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.1

Next Earnings Date: Nov 14, 2025

ATXS Latest Analysis

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX. ATXS stock jumps 37% after agreeing to a $700 million cash-and-stock buyout by BioCryst boosting the latters HAE treatment pipeline.

Wed Oct 15, 2025

$11.92 | +2.67%

Activity

Momentum

Astria Therapeutics: Pipeline And Market Potential Post BioCryst Acquisition.

Wed Oct 15, 2025

$11.92 | +2.67%

Activity

BioCryst Says Astria Therapeutics $700 Million Deal Gives Perfect Second Product Candidate. ) on Tuesday agreed to acquire ATXS) for a mix of cash and stock.The deal represents an implied value of $13 per Astria share and approximately .BioCryst will acquire all outstanding shares of Astria for consideration per share consisting of $8.55 in cash and 0.59 shares of BioCryst stock.Astria is a biopharmaceutical company focused on developing therapies for .Also Read: The transaction is expected in t

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

Potential

BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal . (RTTNews) - BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday said it has agreed to acquire Astria Therapeutics Inc. (ATXS) for an enterprise value of about $700 million to be paid in cash and stock. Following the announcement Astria shares surged more than 35% in pre-market tr

Tue Oct 14, 2025

$11.61 | +37.07%

Momentum

BioCryst to buy Astria Therapeutics for $13 per share (update).

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

BioCryst to Acquire Astria Therapeutics Strengthening Presence in HAE Transforming Growth Profile. – Deal to add navenibart a late-stage and long-acting plasma kallikrein inhibitor in Phase 3 clinical development to BioCrysts HAE portfolio –

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

BioCryst To Acquire Astria Therapeutics In $700 Mln Cash-and-Stock Deal . (RTTNews) - BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday announced it has entered into a definitive agreement to acquire Astria Therapeutics Inc. (ATXS) a biopharmaceutical company for cash and stock valued at approximately $13.00 per Astria share representing an enterpr

Tue Oct 14, 2025

$11.61 | +37.07%

Activity

Discover ATXS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ATXS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ATXS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ATXS Stock trends

ATXS Stock performance

ATXS Stock analysis

ATXS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ATXS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ATXS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ATXS Stock Analysis & IQ Rating | Astria Therapeutics Inc.

ATXS Stock IQ

ATXS Target Price

ATXS Risk Level

ATXS Analysts Opinion

ATXS Street Consensus

ATXS Performance Sentiment

Technical Price Levels

ATXS Financial Health

Explore our ATXS Stock insights

Receive our ATXS Daily Alerts

ATXS Stock IQ

ATXS Street Consensus

ATXS Risk Level

Technical Price Levels

Discover ATXS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ATXS. We're here to help you make informed investment decisions today.

Receive our ATXS Daily Alerts

ATXS Runner Alarm